Home > Products > Novel inhibitors

Novel inhibitors

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC4727 Silagaba132 Silicon-Containing GABA Derivative, Treating Neuropathic Pain without Central-Nervous-System-Related Side Effects
DCC4728 Silagaba161 Silicon-Containing GABA Derivative, Treating Neuropathic Pain without Central-Nervous-System-Related Side Effects
DCC4729 Sila-ibuprofen Novel COX-I and COX-II inhibitor with four times higher solubility in physiological media and a lower melting enthalpy than ibuprofen
DCC4730 Simfibrate Peroxisome proliferator
DCC4731 Sinapine Sulfate Antioxidant and antimicrobial agent, counteracting mitochondrial oxidative stress in cardiomyocytes
DCC4732 Sipi-6360 Novel D2/5-HT2A Receptor Dual Antagonist
DCC4733 Sipi-7623 Novel farnesoid X receptor antagonist
DCC4734 Sirt1-a2 Novel SIRT1 Activator
DCC4735 Sirt1-enhancer-a03 First-in-class apolipoprotein E4 (ApoE4)-targeted sirtuin1 (SirT1) enhancer, normalizing sirtuin 1 levels and improving cognition in an Alzheimer's disease mouse model
DCC4736 Sirt1-i5 Novel SIRT1 Inhibitor, showing potent effect on prostate cancer cell line
DCC4737 Sirt1-in-4bb Novel SIRT1 inhibitor, inducing apoptosis in HCT116 human colon carcinoma cells partially by activating p53
DCC4738 Sirt2-in-6f Potent and selective inhibitor of SIRT2
DCC4739 Sirt3 Inhibitor P6 Novel selective SIRT3 inhibitor, exhibiting SIRT3 inhibitory selectivity with IC50 value of 7.2 µM over SIRT1 (32.6 µM) and SIRT2 (33.5 µM), showing potent inhibitory activity against a group of MLLr leukemic cell lines
DCC4740 Sir-tz Novel in situ tetrazine ligation reactive silicon-rhodamine dye
DCC4741 Sitafloxacin Potent broad spectrm fluoroquinolone antibiotic
DCC4742 Sitafloxacin Monohydrate Fluoroquinolone antibiotic, acting as antibacterial, antineoplastic, anti-Infective agents, Inhibiting DNA-gyrase and topoisomerase
DCC4743 Si-w052 Novel inhibitor of lipopolysaccharide (LPS)-induced tumor necrosis factor (TNF)-α and interleukin (IL)-6 on microglia, exhibiting anti-inflammatory activity through ER-stress-mediated autophagy, significantly inducing the conversion ratio of LC3 II/I and
DCC4744 Sj1008066 Novel inhibitor of MAGE-A11 with robust activity in TR-FRET for disrupting MAGE-A11:PCF11 interactionm being cell permeable and having improved activity in the TR-FRET assay (IC50 0.13 µM)
DCC4745 Sj3366 Unique and highly potent nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1), also inhibiting HIV-2
DCC4746 Sj521054 Novel inhibitor of MAGE-A11 with robust activity in TR-FRET for disrupting MAGE-A11:PCF11 interaction (IC50 0.40 μM)
DCC4747 Sj572710 Novel Inhibitor of the Disordered Protein, p27(Kip1)
DCC4748 Sj-bis Novel selective MDMX antagonist
DCC4749 Sjf-0628 Novel BRAF-targeting PROTAC, inducing efficient and potent degradation of mutant BRAF but sparing BRAFWT, inhibiting cell growth in mutant-BRAF driven cancer cells
DCC4750 Sjf-1521 Novel selective EGFR degrader
DCC4751 Sjf-1528 Novel potent EGFR degrader, being capable of penetrating the cell membrane, also degrading an exon-20 insertion mutant form of EGFR (ASV duplication)
DCC4752 Sjg-136 Novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity
DCC4753 Sjp-l-5 Novel inhibitor of HIV-1 infection by blocking viral DNA nuclear entry
DCC4754 Sk-575 Highly potent and efficacious proteolysis targeting chimera (PROTAC) degrader of PARP1 for treating cancers, potently inhibiting the growth of cancer cells bearing BRCA1/2 mutations and inducing potent and specific degradation of PARP1 in various human ca
DCC4755 Skf64346 Hydrochloride Inhibitor of Aβ self-aggregation
DCC4756 Skf-80723 Hydrobromide Dopamine D1 receptor agonist

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X